On Oct 3, 2023, the US Food and Drug Administration (FDA) proposed to close what critics call a loophole in the nation’s regulatory framework that allows the use of many in-vitro laboratory tests without government scrutiny.
[News] US FDA proposes stronger laboratory test oversight
For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –
LATEST
Sign up for our emails
Trusted insights straight to your inbox and get the latest updates from OncWeekly
Newsletter
Privacy Policy